| Nasdaq: NURO
NeuroMetrix, Inc. is a medical device company that develops and markets home use and point-of-care devices for the treatment and management of chronic pain, peripheral neuropathies, and associated neurological disorders. It focuses on diabetic neuropathies. The company markets the SENSUS Pain Management System for treating chronic pain, focusing on physicians managing patients with painful diabetic neuropathy. The company also markets the DPNCheck device, which is a rapid, accurate, and quantitative point-of-care test for diabetic neuropathy. This product is used to detect diabetic neuropathy at an early stage and to guide treatment. NeuroMetrix was founded by Shai N. Gozani in June 1996 and is headquartered in Waltham, MA.